Genoray Co. Ltd
Genoray Co., Ltd. engages in the research, development, manufacture, and sale of medical and dental x-ray devices in South Korea. It offers C-ARM and mammography medical x-ray devices; and 2D, 3D, ENT, and IOS/IOX dental x-ray devices, as well as related maintenance and repair services. The company also exports its products to approximately 80 countries worldwide. Genoray Co., Ltd. was founded in… Read more
Genoray Co. Ltd (122310) - Total Assets
Latest total assets as of September 2025: ₩125.67 Billion KRW
Based on the latest financial reports, Genoray Co. Ltd (122310) holds total assets worth ₩125.67 Billion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Genoray Co. Ltd - Total Assets Trend (2015–2024)
This chart illustrates how Genoray Co. Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Genoray Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Genoray Co. Ltd's total assets of ₩125.67 Billion consist of 59.8% current assets and 40.2% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩16.18 Billion | 0.0% |
| Accounts Receivable | ₩8.60 Billion | 7.0% |
| Inventory | ₩43.73 Billion | 35.4% |
| Property, Plant & Equipment | ₩30.83 Billion | 25.0% |
| Intangible Assets | ₩9.19 Billion | 7.5% |
| Goodwill | ₩206.00 Million | 0.2% |
Asset Composition Trend (2015–2024)
This chart illustrates how Genoray Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Genoray Co. Ltd's current assets represent 59.8% of total assets in 2024, an increase from 58.3% in 2015.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2024, down from 9.2% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, a decrease from 23.0% in 2015.
- Asset Diversification: The largest asset category is inventory at 35.4% of total assets.
Genoray Co. Ltd Competitors by Total Assets
Key competitors of Genoray Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
|
Optipharm.CO.LTD
KQ:153710
|
Korea | ₩42.32 Billion |
|
Bionet
TWO:1784
|
Taiwan | NT$3.10 Billion |
|
Cytogen Inc
KQ:217330
|
Korea | ₩67.68 Billion |
Genoray Co. Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Genoray Co. Ltd generates 0.87x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Genoray Co. Ltd is currently not profitable relative to its asset base.
Genoray Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.94 | 2.30 | 3.62 |
| Quick Ratio | 0.70 | 0.83 | 2.28 |
| Cash Ratio | 0.00 | 0.16 | 0.00 |
| Working Capital | ₩36.99 Billion | ₩ 42.23 Billion | ₩ 46.12 Billion |
Genoray Co. Ltd - Advanced Valuation Insights
This section examines the relationship between Genoray Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.65 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -0.7% |
| Total Assets | ₩123.44 Billion |
| Market Capitalization | $24.43 Million USD |
Valuation Analysis
Below Book Valuation: The market values Genoray Co. Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Genoray Co. Ltd's assets decreased by 0.7% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Genoray Co. Ltd (2015–2024)
The table below shows the annual total assets of Genoray Co. Ltd from 2015 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩123.44 Billion | -0.66% |
| 2023-12-31 | ₩124.27 Billion | +17.02% |
| 2022-12-31 | ₩106.20 Billion | +6.87% |
| 2021-12-31 | ₩99.37 Billion | +15.89% |
| 2020-12-31 | ₩85.74 Billion | +9.20% |
| 2019-12-31 | ₩78.52 Billion | +34.36% |
| 2018-12-31 | ₩58.44 Billion | +54.88% |
| 2017-12-31 | ₩37.73 Billion | +13.01% |
| 2016-12-31 | ₩33.39 Billion | +17.00% |
| 2015-12-31 | ₩28.54 Billion | -- |